These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7976208)

  • 21. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 10 of pigs vaccinated with bacterins consisting of A. pleuropneumoniae serotype 10 grown under NAD-rich and NAD-restricted conditions.
    van Overbeke I; Chiers K; Donne E; Ducatelle R; Haesebrouck F
    J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):289-93. PubMed ID: 14629000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response in sows and piglets following vaccination against Mycoplasma hyopneumoniae, toxigenic Pasteurella multocida, and Actinobacillus pleuropneumoniae.
    Kristensen CS; Andreasen M; Ersbøll AK; Nielsen JP
    Can J Vet Res; 2004 Jan; 68(1):66-70. PubMed ID: 14979438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge.
    Hensel A; Stockhofe-Zurwieden N; Petzoldt K; Lubitz W
    Infect Immun; 1995 Aug; 63(8):3048-53. PubMed ID: 7622229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria.
    Lee KY; Kim DH; Kang TJ; Kim J; Chung GH; Yoo HS; Arntzen CJ; Yang MS; Jang YS
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):381-9. PubMed ID: 17054716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals.
    Maas A; Jacobsen ID; Meens J; Gerlach GF
    Infect Immun; 2006 Jul; 74(7):4124-32. PubMed ID: 16790786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.
    Inzana TJ; Todd J; Veit HP
    Infect Immun; 1993 May; 61(5):1682-6. PubMed ID: 8478056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model.
    Hensel A; van Leengoed LA; Szostak M; Windt H; Weissenböck H; Stockhofe-Zurwieden N; Katinger A; Stadler M; Ganter M; Bunka S; Pabst R; Lubitz W
    J Biotechnol; 1996 Jan; 44(1-3):171-81. PubMed ID: 8717401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination.
    Beaudet R; McSween G; Boulay G; Rousseau P; Bisaillon JG; Descoteaux JP; Ruppanner R
    Vet Microbiol; 1994 Mar; 39(1-2):71-81. PubMed ID: 8203129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute toxicity and immunoprotection of recombinant apxI toxin of Actinobacillus pleuropneumoniae in mice].
    Yan KX; Liu JJ; Zhou R; Wu B; Liu WH; Chen HC
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):65-70. PubMed ID: 16572842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue reaction and immunity in swine immunized with Actinobacillus pleuropneumoniae vaccines.
    Willson PJ; Rossi-Campos A; Potter AA
    Can J Vet Res; 1995 Oct; 59(4):299-305. PubMed ID: 8548692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic and local antibody responses after experimental infection with Actinobacillus pleuropneumoniae in piglets with passive or active immunity.
    Krejci J; Nechvatalova K; Kudlackova H; Faldyna M; Kucerova Z; Toman M
    J Vet Med B Infect Dis Vet Public Health; 2005 May; 52(4):190-6. PubMed ID: 16000115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel experimental model for the study and evaluation of experimental vaccines to Actinobacillus pleuropneumoniae.
    Montaraz JA; Rosales ME; Bautista E; Barcenas G; Lara V
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):375-80. PubMed ID: 7941315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Actinobacillus pleuropneumoniae virulence genes using signature-tagged mutagenesis in a swine infection model.
    Fuller TE; Martin S; Teel JF; Alaniz GR; Kennedy MJ; Lowery DE
    Microb Pathog; 2000 Jul; 29(1):39-51. PubMed ID: 10873489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental vaccination of pigs with an Actinobacillus pleuropneumoniae serotype 5b capsular polysaccharide-tetanus toxoid conjugate.
    Andresen LO; Jacobsen MJ; Nielsen JP
    Acta Vet Scand; 1997; 38(3):283-93. PubMed ID: 9444782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variability in swine leukocyte antigen class II and Toll-like receptors affects immune responses to vaccination for bacterial infections in pigs.
    Shinkai H; Arakawa A; Tanaka-Matsuda M; Ide-Okumura H; Terada K; Chikyu M; Kawarasaki T; Ando A; Uenishi H
    Comp Immunol Microbiol Infect Dis; 2012 Dec; 35(6):523-32. PubMed ID: 22658914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and characterization of a live, attenuated apxIICA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker.
    Bei W; He Q; Yan L; Fang L; Tan Y; Xiao S; Zhou R; Jin M; Guo A; Lv J; Huang H; Chen H
    FEMS Microbiol Lett; 2005 Feb; 243(1):21-7. PubMed ID: 15667996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of protective immunity and inflammatory responses of pigs following immunization with different Actinobacillus pleuropneumoniae preparations with and without adjuvants.
    Hall W; Molitor TW; Joo HS; Pijoan C
    Vet Immunol Immunopathol; 1989 Sep; 22(2):175-86. PubMed ID: 2815578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral immunization using formalin-inactivated Actinobacillus pleuropneumoniae antigens entrapped in microspheres with aqueous dispersion polymers prepared using a co-spray drying process.
    Liao CW; Chiou HY; Yeh KS; Chen JR; Weng CN
    Prev Vet Med; 2003 Sep; 61(1):1-15. PubMed ID: 14516713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a single dose versus a divided dose regimen of amoxycillin in treatment of Actinobacillus pleuropneumoniae infection in pigs.
    Lauritzen B; Lykkesfeldt J; Friis C
    Res Vet Sci; 2005 Aug; 79(1):61-7. PubMed ID: 15894026
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Quan K; Zhu Z; Cao S; Zhang F; Miao C; Wen X; Huang X; Wen Y; Wu R; Yan Q; Huang Y; Ma X; Han X; Zhao Q
    J Microbiol Biotechnol; 2018 Dec; 28(12):2095-2105. PubMed ID: 30380823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.